| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,228 |
8,898 |
$805K |
| S4993 |
Contraceptive pills for birth control |
6,691 |
6,538 |
$732K |
| J3490 |
Unclassified drugs |
15,590 |
14,006 |
$729K |
| S0199 |
Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs |
1,121 |
1,103 |
$695K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
613 |
565 |
$659K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,797 |
6,522 |
$435K |
| 87806 |
|
14,950 |
13,425 |
$411K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,212 |
2,174 |
$326K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
7,196 |
7,034 |
$314K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,452 |
2,377 |
$273K |
| 59840 |
|
1,001 |
636 |
$205K |
| 99201 |
|
1,829 |
1,821 |
$170K |
| 58300 |
|
1,090 |
625 |
$124K |
| A4267 |
Contraceptive supply, condom, male, each |
10,643 |
10,357 |
$116K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
659 |
657 |
$113K |
| 11981 |
|
483 |
442 |
$106K |
| 0520 |
|
670 |
333 |
$95K |
| S0190 |
Mifepristone, oral, 200 mg |
1,005 |
980 |
$69K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
831 |
810 |
$66K |
| J7303 |
Contraceptive supply, hormone containing vaginal ring, each |
98 |
94 |
$63K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
3,110 |
3,110 |
$40K |
| 81025 |
|
12,328 |
11,995 |
$38K |
| 11976 |
|
560 |
280 |
$35K |
| J7300 |
Intrauterine copper contraceptive (paragard) |
39 |
39 |
$34K |
| 86780 |
|
2,889 |
2,886 |
$33K |
| A4649 |
Surgical supply; miscellaneous |
2,268 |
1,914 |
$30K |
| 86703 |
|
2,610 |
2,319 |
$28K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
24 |
24 |
$23K |
| S5000 |
Prescription drug, generic |
2,174 |
2,048 |
$23K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
732 |
680 |
$21K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
695 |
645 |
$20K |
| 99152 |
|
368 |
362 |
$20K |
| 86803 |
|
1,150 |
1,147 |
$17K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
14 |
12 |
$14K |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
1,669 |
1,314 |
$10K |
| 83986 |
|
3,101 |
2,745 |
$10K |
| J7304 |
Contraceptive supply, hormone containing patch, each |
12 |
12 |
$10K |
| 87808 |
|
864 |
835 |
$9K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
254 |
194 |
$9K |
| 58301 |
|
258 |
131 |
$9K |
| 99000 |
|
1,977 |
1,960 |
$8K |
| 87210 |
|
2,013 |
1,723 |
$7K |
| J7295 |
Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each |
12 |
12 |
$7K |
| 99402 |
|
176 |
176 |
$6K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
43 |
43 |
$5K |
| 64435 |
|
155 |
141 |
$5K |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
1,008 |
962 |
$4K |
| 85018 |
|
1,059 |
979 |
$2K |
| 11982 |
|
32 |
16 |
$2K |
| 90674 |
|
59 |
57 |
$2K |
| 81002 |
|
780 |
753 |
$2K |
| S0191 |
Misoprostol, oral, 200 mcg |
1,222 |
1,174 |
$1K |
| 0300 |
|
140 |
91 |
$921.79 |
| 88142 |
|
69 |
69 |
$823.46 |
| 86901 |
|
316 |
302 |
$733.09 |
| 86592 |
|
129 |
129 |
$524.81 |
| 99401 |
|
50 |
50 |
$447.50 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$269.51 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
39 |
37 |
$216.27 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
34 |
33 |
$155.15 |
| 86701 |
|
14 |
14 |
$101.42 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
62 |
62 |
$21.45 |